HRSA Launches 340B Ceiling Price Website
On April 1, 2019, HRSA launched its secure pricing component of the 340B OPAIS. This long overdue website allows safety-net providers access to a database of 340B ceiling prices. The…
HHS Files Status Report on Publishing of 340B Ceiling Prices
On February 28, 2019, the U.S. Department of Health and Human Services (HHS) filed a status report with the U.S. District Court for the District of Columbia regarding its progress…
HHS Appeals Permanent Injunction Stopping 340B Reimbursement Cuts
The Department of Health and Human Services (HHS) appealed the U.S. District Court for the District of Columbia’s decision to enjoin payment cuts for 340B drugs under the 2018 Outpatient…
Hospital Groups File Amended Complaint to Compel HRSA to Publish 340B Ceiling Prices
On December 20th, the national hospital groups that brought a lawsuit against HHS over the continued delay of the implementation date of the 340B Ceiling Price and Manufacturer Civil Monetary…
Court Rules in Hospitals’ Favor in 340B OPPS Cuts Lawsuit
On December 27, 2018, the U.S. District Court for the District of Columbia struck down the portion of the 2018 OPPS rule that cut Medicare Part B drug reimbursement to…
HRSA to Begin Publishing 340B Ceiling Prices in 2019
Today, HRSA announced that it will begin publishing 340B ceiling prices starting April 1, 2019. HRSA will collect manufacturer pricing data on a quarterly basis and use the data to…
HHS Finalizes Manufacturer CMP and Penny Pricing Rule Effective January 1, 2019
Earlier today, HHS published a final rule to implement the 340B Ceiling Price and Manufacturer Civil Monetary Penalties Rule (CMP Rule) on January 1, 2019. The Affordable Care Act (ACA)…
RWC-340B Leaders Meet with HRSA Administrator and Key HHS Staff
On October 29, 2018, RWC-340B leaders met with George Sigounas, M.S., Ph.D., the HRSA Administrator, and Beth Nelson, HHS Health Policy Advisor, to advocate to preserve and protect the 340B…
Proposed Rule Would Require Drug Manufacturers to Disclose Prices in TV Advertisements
On Monday, Health and Human Services Secretary Alex Azar announced a proposed rule that would require pharmaceutical manufacturers to disclose wholesale acquisition cost (“WAC”) prices in direct-to-consumer TV advertisements for…
Hospital Groups File Lawsuit Challenging CMP Rule Delay
Yesterday, four national hospital groups and three hospital systems filed a lawsuit against HHS over the continued delay of the implementation date of the 340B Ceiling Price and Manufacturer Civil…